C
$ Value
—
Shares
855,512
Price
—
Filed
Feb 10
Insider
Name
PERLMUTTER ROGER M
Title
See remarks
CIK
0001184228
Roles
Director
Officer
Transaction Details
Transaction Date
2026-02-06
Code
C
Table
Derivative
Ownership
Indirect
Equity Swap
No
Shares After
—
Footnotes
The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering ("IPO") on a 1-for-7.4578 basis and had no expiration date. | The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date. | The securities are held indirectly by the Reporting Person through Perlmutter Consulting, Inc. for the benefit of the Reporting Person. The Reporting Person had the sole pecuniary interest in the securities.
Filing Info
PERLMUTTER ROGER M's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | EIKN | A | $0 |
| 2026-02-06 | EIKN | C | — |
| 2026-02-06 | EIKN | C | — |
| 2026-02-06 | EIKN | C | — |
Other Insiders at EIKN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Column Group IV GP, LP | $38.1M | — | 2026-02-06 |
| Lux Venture Partners V, LLC | $5.0M | — | 2026-02-06 |
| Wolfe Josh | $5.0M | — | 2026-02-06 |
| FRAZIER KENNETH C | $2.0M | — | 2026-03-02 |
| Foresite Capital Management IV, LLC | $1000K | — | 2026-02-04 |
|
PERLMUTTER ROGER M
See remarks
|
— | — | 2026-03-02 |
|
Baynes Roy D.
Chief Medical Officer
|
— | — | 2026-03-02 |
| Huffines Robert Luther | — | — | 2026-03-02 |
|
Klobuchar Michael A
Chief Operating Officer
|
— | — | 2026-03-02 |
|
Thorner Benjamin Bruno
See Remarks
|
— | — | 2026-03-02 |
|
Bowie Alfred Lloyd Jr.
Chief Financial Officer
|
— | — | 2026-03-02 |